Difficult-to-treat Beh?et syndrome: A therapeutic approach

Yazici Y., HATEMİ G.

CLINICAL IMMUNOLOGY, cilt.249, 2023 (SCI-Expanded, Scopus) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 249
  • Basım Tarihi: 2023
  • Doi Numarası: 10.1016/j.clim.2023.109272
  • Dergi Adı: CLINICAL IMMUNOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, BIOSIS, CAB Abstracts, Chemical Abstracts Core, EMBASE, MEDLINE, Veterinary Science Database
  • Anahtar Kelimeler: Behcet syndrome, Outcomes, Disease activity, Azathioprine, Personalized medicine, BEHCETS-DISEASE, DOUBLE-BLIND, FOLLOW-UP, TRIAL, APREMILAST, DIAGNOSIS, EFFICACY, PHASE-2
  • İstanbul Üniversitesi-Cerrahpaşa Adresli: Hayır

Özet

Behcet syndrome is a systemic vasculitis which can involve many different organ systems. As such, treatment decisions need to be based on organ system involved. In addition, specific patient characteristics potentially predict milder or more severe course, and all these factors need to be taken into consideration when making treatment decisions. In this paper, we review the current approaches to treating Behcet syndrome patients.